Resource Centers
Pulmonary Medicine CME
- Improving Use of Therapies in the Management of Chronic Obstructive Pulmonary Disease
- Treatment Strategies for Pulmonary Arterial Hypertension: Keeping Up With the Clinical Data and Addressing Treatment Failure in PAH
- A 40-Year-Old African American Patient With Daily Shortness of Breath
- Shortness of Breath With Chest Pressure in A 55-Year-Old Man
- Non-small-cell Lung Cancer: Evolving Treatment Strategies and Personalizing Therapy
- The Basic Geriatric Respiratory Examination
- A 50-Year-Old Woman With an Incidental But Significant Skin Finding
- Stroke Management Update: Research Highlights of 2008
- Circadian Sleep-Wake Rhythm Disturbances in End-Stage Renal Disease
- New Advances in the First-line Treatment of Non-Small Cell Lung Cancer
- Management of Chronic Sleep-Maintenance Insomnia
- Controversies in HIV: Management of the Treatment-Naive Patient
- An Uncommon Cause of Chest Pain in a Healthy Young Man
- A Primer on HIV Testing and Initial Treatment
- Advancing Insomnia Treatment to Enhance Quality of Sleep
- Latest Evidence on Screening, Diagnosis, and Treatment of Hereditary Angioedema
- Emergent Treatment of a Deep Vein Thrombosis: What Is the Best Approach?
- An Update on Sick Building Syndrome
- A Clinical Dialogue on Hereditary Angioedema and Other Forms of Angioedema
- Optimizing Diagnosis, Management, and Prevention of Venous Thromboembolism
News CME
- Severe Community-Acquired Pneumonia Score May Help Predict Adverse Outcomes
- FDA Safety Changes: Prevpac, Arava, Treanda
- More Details on Arrhythmias Associated With Sleep Apnea
- Statin Use Not Linked to Decreased Risk for Pneumonia in Immunocompetent Elderly
- Acute Lung Injury, Acute Respiratory Distress Syndrome Management in Children Reviewed
Medical Education Content
- Guidelines for Submitting Adverse Event Reports for Publication
- The Importance of Early Diagnosis and Treatment of Pulmonary Arterial Hypertension
- Recent Data on the Treatment of Pulmonary Arterial Hypertension: An Expert Interview With Dr. Steven Nathan
- Clinical and Molecular Biomarkers in Non-Small-Cell Lung Cancer
- Obama vs McCain: Impact on HHS and the FDA in the Next Administration
- CHEST 2008: American College of Chest Physicians 74th Annual Scientific Assembly
- European Respiratory Society (ERS) 2008 Annual Congress
- Why Should I Report an Adverse Drug Event?
- Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary Arterial Hypertension: The EARLY Study
- Intravenous Prostacyclin Analogs for the Treatment of Pulmonary Arterial Hypertension
- New Pulmonary Arterial Hypertension Treatment Data to Update Clinical Practice
- Using Combination Therapies in the Treatment of Pulmonary Arterial Hypertension: What's on the Horizon?
- Postexercise Evaluation of Pulmonary Artery Pressure
- Pulmonary Arterial Hypertension and Cardiovascular Mortality in Patients With Rheumatoid Arthritis
- Overcoming Barriers to Reporting Adverse Drug Events
- Oral VEGF Therapies in Lung Cancer
- Transplantation Criteria for Patients With Severe Pulmonary Hypertension and Grossly Impaired Right, but Relatively Normal Left Ventricular Function
- American Thoracic Society (ATS) 2008 International Conference
- Transmission of Influenza Virus: What Is Keeping the Next Pandemic at Bay?
- Autoimmune Diseases and Pulmonary Arterial Hypertension
Advisory Board
- James F. Donohue, MD
- Christopher J. Lettieri, MD
- Neil MacIntyre, MD
- Steven Nathan, MD
- Michael S. Niederman, MD
- Mark O'Hollaren, MD
- Andrew F. Shorr, MD, MPH, FCCP
Scientific Director
Policies and Requirements